Sign inJoin waitlistJoin the waitlist

Mazen Khalil

Faculty, Internal Medicine Residency Program · St. Bernards Medical Center

Credentials: · · · ·

History

St. Bernards Medical Center
Present

Hematology and Medical Oncology
University of Texas Health Science Center at San Antonio
University of Pittsburg Medical Center
UPMC
Tishreen University Faculty of Medicine

Research

A phase 1/2 trial of ublituximab, a novel anti-CD20 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma or chronic lymphocytic leukaemia previously exposed to…
British Journal of Haematology · 2017 · 65 citations
Targeting epidermal growth factor receptor: novel therapeutics in the management of cancer
Review · Expert Review of Anticancer Therapy · 2003 · First of 3 authors · Corresponding · 55 citations
Real-world performance of blood-based proteomic profiling in first-line immunotherapy treatment in advanced stage non-small cell lung cancer
Journal for ImmunoTherapy of Cancer · 2021 · 19 citations

AK
Amber Kuta
2 papers · 2 as a resident
Dong Shin
2 papers
Linda Youn
2 papers · 2 as a resident
MS
Mirra Srinivasan
2 papers · 2 as a resident
AS
Ahmed Sawas
1 paper
AV
Andrea Veatch
1 paper
AB
Andrew Beaver
1 paper · 1 as a resident
BG
Bassam Ghabach
1 paper
Changchun Deng
1 paper
Charles Farber
1 paper
CO
Coleman Obasaju
1 paper
Daruka Mahadevan
1 paper

Clinical trials

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
Site PI · Recruiting · Phase 3
GlaxoSmithKline
2024–2029